LEVBIO — Level Bio AB (publ) Share News
0.000.00%
- SEK19.43m
- SEK18.25m
- SEK32.36m
Brief: Alphahelix Molecular Diagnostics Signs Development And Distribution Agreement With Partner In China
Brief: AlphaHelix Molecular Diagnostics Q1 Net Result Swings To Loss Of SEK 922,000
Brief: Alphahelix Molecular Diagnostics Q4 Net Result Swings To Loss Of Sek 843,000
Brief: AlphaHelix Signs Contract For Distribution In Benelux
Brief: AlphaHelix Molecular Diagnostics Gets Distribution Contract In Israel
Brief: AlphaHelix Molecular Diagnostics signs deal with new distributors in Asia
Brief: AlphaHelix appoints Peter Herte as new CEO
Brief: AlphaHelix to change stock exchange to Nasdaq First North
Brief: AlphaHelix: Mattias Molin resigns as CEO
Brief: AlphaHelix sells BugScreener to Finland
Brief: AlphaHelix signs cooperation agreement with Expression Analytics
Brief: Alphahelix takes over MRSA platform from Techtum Lab
Brief: AlphaHelix: Örebro University with Techtum as technical cooperation partner
Brief: AlphaHelix: Roche terminates all Kapa Biosystem's distributor agreements
Brief: AlphaHelix: Techtum Biobanking wins procurement
Brief: AlphaHelix: Techtum receives order in Denmark
Brief: AlphaHelix delivers MRSA-platform to Finland